Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
9 papers
Recent·Most cited
Y. B. Tam, K. Low, H. PS, M. Chadha, J. Burns, C. Wilding, A. Arthur, T. Chen, K. Thway, A. Sadanandam, R. Jones, P. H. Huang
This study compares proteomic profiles of adolescents and young adults with soft tissue tumours to older adults, identifying age-specific molecular features and potential therapeutic targets.
bioRxiv · Nov 18, 2023Cancer Biology
S. M. M. Aalam, X. Tang, H. PS, S. M. Salem, A. Al-jarrad, P. A. Noseworthy, A. Behfar, A. Sadanandam, K. R. Kalari, P. C. Kashyap, N. Kannan
The paper shows that gut microbiota prevents sudden cardiac death in mice by suppressing occult cardiac sub-micrometastases.
bioRxiv · Jul 3, 2023 · PreprintCancer Biology
C. Ragulan, K. Desai, P. V. Lawrence, Y. Ikami, M. M. Aalam, H. Ps, N. Kannan, D. Cunningham, N. Starling, A. Sadanandam
This study identifies GITR agonism as a potential enhancer of anti-PD-L1 and CD40-based immunotherapy in pancreatic tumors by targeting immune evasion mechanisms.
bioRxiv · Jun 16, 2023 · PreprintCancer Biology
D. H. Tow, C. G. Tran, L. C. Borbon, M. Ridder, G. Li, C. A. Kaemmer, E. Abusada, A. H. Mahalingam, A. Sadanandam, C. Chandrasekharan, J. Dillon, D. R. Spitz, D. E. Quelle, C. H. F. Chan, A. M. Bellizzi, , P. H. Ear
This study shows that inhibiting serotonin biosynthesis in neuroendocrine neoplasms reduces tumor growth in vivo but not in vitro.
bioRxiv · Apr 7, 2023 · PreprintCancer Biology
A. Korlimarla, H. PS, J. Prabhu, C. Ragulan, Y. Patil, S. VP, K. Desai, A. Mathew, S. Appachu, R. Diwakar, S. BS, M. Cheang, A. Sadanandam
This study identifies three immune subtypes in Indian triple-negative breast cancer patients, showing similarities to Western TNBCs and potential for immunotherapy response.
bioRxiv · Mar 6, 2022 · PreprintCancer Biology
M. H. Ward, Z. C. Nwosu, P. Poudel, S. Kasperek, Z. Tolstyka, R. E. Menjivar, C. Ragulan, G. Nyamundanda, L. Zhang, A. Andren, C. J. Halbrook, E. S. Carpenter, M. Pasca di Magliano, A. Sadanandam, C. A. Lyssiotis
This study identifies uridine as a novel nutrient for pancreatic cancer cells through uridine phosphorylase 1, showing its role in survival and metabolism under glucose deprivation.
bioRxiv · Jun 7, 2021 · PreprintCancer Biology
A. M. Khaliq, z. kurt, M. W. Grunvald, C. Erdogan, S. S. Turgut, T. Rand, S. Khare, J. A. Borgia, D. M. Hayden, S. G. Pappas, H. R. Govekar, A. R. Bhama, A. Singh, R. A. Jacobson, A. E. Kam, , A. Masood
This paper constructs a single-cell transcriptome atlas of colorectal cancer to reveal subclonal heterogeneity and identify CAF subtypes associated with survival and immunotherapy resistance.
bioRxiv · Feb 2, 2021 · PreprintCancer Biology
C. Ragulan, K. Eason, G. Nyamundanda, Y. Patil, P. Poudel, E. Fontana, M. Del Rio, S.-L. Koo, W. S. Tan, P. Martineau, D. Cunningham, I. Tan, A. Sadanandam
The paper validates a NanoString-based biomarker assay for classifying colorectal cancer samples into molecular subtypes with high concordance across platforms and tissue types.
Scientific Reports · May 21, 2019Peer-reviewedCancer Biology
A. Woolston, K. Khan, G. Spain, L. J. Barber, B. Griffiths, R. Gonzalez Exposito, Y. Patil, S. Mansukhani, M. N. Davies, A. Furness, F. Sclafani, C. Peckitt, K. Kouvelakis, R. Ranftl, R. Begum, , M. Gerlinger
The paper analyzes genomic and transcriptomic data from CRC patients treated with cetuximab to identify resistance mechanisms and immune landscape changes during anti-EGFR therapy.
bioRxiv · Oct 19, 2018Cancer Biology